UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): May 31, 2007
MEDecision, Inc.
(Exact Name of Issuer as Specified in Charter)
Pennsylvania | | 001-33191 | | 23-2530889 |
(State or Other Jurisdiction of | | (Commission File Number) | | (I.R.S. Employer Identification |
Incorporation or Organization) | | | | Number) |
| | | | |
601 Lee Road, Chesterbrook Corporate Center
Wayne, Pennsylvania | | 19087 |
(Address of Principal Executive Offices) | | (Zip Code) |
(610) 540-0202
(Registrant’s Telephone Number, Including Area Code)
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act
Item 1.01. Entry into a Material Definitive Agreement.
On May 31, 2007, we and InterSystems Corporation entered into an amendment (the “Amendment”) of the Value Added Remarketing Agreement (the “VAR Agreement”) among us and InterSystems Corporation pursuant to which InterSystems Corporation has agreed to extend until May 31, 2012 its license to us of a database module that is utilized in our Advanced Medical Management module. In addition, we agreed to new pricing terms under the VAR Agreement (the “Amended and Restated Price List”).
A copy of the Amended and Restated Price List and the Amendment are attached hereto as Exhibits 10.14(iii) and 10.14(v), respectively, and are incorporated herein by reference. The foregoing description of the Amended and Restated Price List and the Amendment is qualified in its entirety by reference to the full text of the Amended and Restated Price List and the Amendment.
Item 9.01. Financial Statements and Exhibits.
(d) The following exhibits are furnished with this Form 8-K:
Exhibit No. | | Description |
| | |
10.14(iii) | # | Amended and Restated Price List. |
| | |
10.14(v) | | Amendment to Value Added Remarketing Agreement between MEDecision, Inc. and InterSystems Corporation dated May 31, 2007. |
# An application has been submitted to the Securities and Exchange Commission for confidential treatment, pursuant to Rule 406 of the Securities Act of 1933 and Rule 24b-2 of the Securities Exchange Act of 1934, of portions of these exhibits. These portions have been omitted from these exhibits.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MEDECISION, INC. |
| |
| |
Date: June 6, 2007 | By: | /s/ Carl E. Smith | |
| | Name: Carl E. Smith |
| | Title: Executive Vice President and |
| | Chief Financial Officer |
3
EXHIBIT INDEX
Exhibit
Number | | | | Description |
| | | | |
10.14(iii) | | # | | Amended and Restated Price List. |
| | | | |
10.14(v) | | | | Amendment to Value Added Remarketing Agreement between MEDecision, Inc. and InterSystems Corporation dated May 31, 2007. |
# An application has been submitted to the Securities and Exchange Commission for confidential treatment, pursuant to Rule 406 of the Securities Act of 1933 and Rule 24b-2 of the Securities Exchange Act of 1934, of portions of these exhibits. These portions have been omitted from these exhibits.
4
